Michael J. McElhaugh
Interim President & CEO at Arbutus Biopharma Corporation
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Arbutus Biopharma Corporation, 2 years.
Arbutus Biopharma Corporation
Director · Interim President & CEO
Chief executive roles
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 2, 2024 | Arbutus Biopharma Corporation | Open-market sale | −10,164 | $2.31 | $23,479 |
| Feb 1, 2024 | Arbutus Biopharma Corporation | Grant or award | +123,800 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.